AIM IMMUNOTECH INC. Available-for-sale Securities, Gross Unrealized Gain
AIM IMMUNOTECH INC. (AIM) reported Available-for-sale Securities, Gross Unrealized Gain of $1.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2019-11-14
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for the quarter ending 2019-09-30 was $0.00.
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for the quarter ending 2017-12-31 was -$19.00K.
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for the quarter ending 2017-09-30 was $12.00K.
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for the quarter ending 2017-06-30 was $12.00K, a 67.57% decline year-over-year.
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for fiscal 2017 was $11.00K.
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for fiscal 2013 was $115.00K, a 945.45% increase from fiscal 2012.
- AIM IMMUNOTECH INC. available-for-sale securities, gross unrealized gain for fiscal 2012 was $11.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month | Available-for-sale Securities, Gross Unrealized Gain 12 month as first filed |
|---|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.00K 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | $1.00K 10-Q · filed 2019-08-14 | ||||
| 2017-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$7.00K derived: sum of 2 quarters · filed 2019-04-01 | $5.00K derived: sum of 3 quarters · filed 2019-04-01 | $11.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $24.00K derived: sum of 2 quarters · filed 2017-11-14 | $30.00K 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $18.00K 10-Q · filed 2017-08-14 | |||
| 2017-03-31 | $6.00K 10-Q · filed 2017-05-15 | ||||
| 2016-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $21.00K derived: sum of 2 quarters · filed 2016-11-14 | $71.00K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $87.00K 10-Q · filed 2016-08-15 | |||
| 2016-03-31 | $50.00K 10-Q · filed 2016-05-16 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | -$77.00K derived: sum of 2 quarters · filed 2015-03-19 | $0.00 derived: sum of 3 quarters · filed 2015-03-19 | $0.00 10-K · filed 2015-03-19 | |
| 2014-09-30 | -$77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $77.00K 10-Q · filed 2014-08-08 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | ||||
| 2013-12-31 | $115.00K 10-K · filed 2015-03-19 | $116.00K 10-K · filed 2014-03-14 | |||
| 2012-12-31 | $11.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |